Aerie Pharmaceuticals
Latest round
- Series B
Last raised
- Feb 2011
Total raised
- $51M
Investors
- 6
About Aerie Pharmaceuticals
Aerie Pharmaceuticals, Inc.Founded in 2005 and headquartered in Durham, US, Aerie Pharmaceuticals, Inc. specializes in developing therapies aimed at treating serious ocular conditions. The company has undergone significant transitions, including its recent acquisition by Alcon Labs, Inc. for USD 770 million in August 2022. The firm was co-founded by John Fain, who has a background in developing ophthalmic solutions.000 mn on June 22, 2015, from Deerfield Management.Aerie Pharmaceuticals focuses on creating innovative ophthalmic treatments, primarily targeting glaucoma and ocular hypertension. Its flagship products include Rocklatan®, a combination treatment, and Rhopressa®, both designed to help manage intraocular pressure.955 mn for the same year.Aerie Pharmaceuticals aims to expand its product portfolio by launching new therapies in the coming years, particularly focusing on ophthalmic solutions with anticipated releases in the pipeline targeting ocular conditions. The company plans to penetrate additional international markets to increase its reach, with specific goals set for the next few years.000 mn will support these initiatives and assist in enhancing research capabilities to expedite the development of new therapies.
Who invested in Aerie Pharmaceuticals
6 investors across 2 rounds
See all investors in Aerie Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aerie Pharmaceuticals
Who invested in Aerie Pharmaceuticals?
Aerie Pharmaceuticals has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aerie Pharmaceuticals raised?
Aerie Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aerie Pharmaceuticals last raise money?
Aerie Pharmaceuticals's most recent round on record is a Series B, in Feb 2011.
What does Aerie Pharmaceuticals do?
Aerie Pharmaceuticals is a biotechnology company.
Where is Aerie Pharmaceuticals headquartered?
Aerie Pharmaceuticals is headquartered in Durham, US.
Which VCs invest in companies like Aerie Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aerie Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Aerie Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.